🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
The purpose of this study is to assess the potential effects of ketoconazol...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01626651
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
Mantle Cell Lymphoma (MCL) is a form of Non-Hodgkin Lymphoma (NHL - cancer ...
Status
Completed
Location
NHO Nagoya Medical Center /ID# 221958
Start Date
2020-09-23
Trial ID
NCT04477486
Treatments Being Tested
Allogeneic stem cell transplant is used to treat a variety of blood cancers...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2019-04-11
Trial ID
NCT03689894
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
Phase 2, open-label, non-randomized, monotherapy study to evaluate the safe...
Status
Completed
Location
Site Reference ID/Investigator# 837
Start Date
2013-12
Trial ID
NCT01980628
Treatments Being Tested
A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosi...
Status
Completed
Location
Site Reference ID/Investigator #047
Start Date
2013-03
Trial ID
NCT01722487
Treatments Being Tested
This is a modular study of AZD2014 in combination with novel anti-cancer ag...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02780830
The goal of this clinical research study is to learn how PCI-32765 (ibrutin...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-12-17
Trial ID
NCT01752426
Treatments Being Tested